Clinical Trials in Colorado

Showing 1501-1520 of 8,657 trials

Randomized Blinded Evaluation of the Effects of TENS and IFC Compared to a Sham Device and SOC in Patients With Non-Specific CLBP

NCT05972889

This is a prospective, sham-controlled, randomized, single-blinded, multi-center study comparing two different modes of the NexWave device, transcutaneous electrical nerve stimulation (TENS) and interferential current (IFC), with an identical non-functioning NexWave sham device or self-defined standard of care for improvement of pain intensity of non-specific CLBP.

Non-Specific Chronic Lower Back Pain

Zynex Medical, Inc.334 participantsStarted Nov 2023

Greenwood Village, Colorado, United States • Saint Augustine, Florida, United States • Atlanta, Georgia, United States +5 more locations

RECRUITING53 miles

STXBP1 and SYNGAP1 Related Disorders Natural History Study

NCT06555965

The purpose of this study is to find out more about STXBP1 and SYNGAP1 related disorders. The information gathered by this study will be used to prepare for clinical treatment trials. The primary objective of the study is to better define and outline the clinical spectrum of STXBP1 and SYNGAP1 through detailed developmental, seizure, and quality of life assessments as an extension of routine clinical care.

Genetic DiseaseSTXBP1 Encephalopathy With EpilepsySYNGAP1-Related Intellectual Disability

Children's Hospital of Philadelphia600 participantsStarted Aug 2023

Palo Alto, California, United States • Aurora, Colorado, United States • New York, New York, United States +2 more locations

Randomized Blinded Evaluation of the Effects of TENS and IFC Compared to a Sham Device and SOC in Patients With Non-Specific CLBP

STXBP1 and SYNGAP1 Related Disorders Natural History Study

Find Trials by Condition in Colorado

Individualizing Treatment for Asthma in Primary Care (Full Study)

Alcohol and Sexual Communication Among Couples in the Laboratory

A Clinical Trial to Investigate Long-term Safety, Tolerability, and Efficacy of Weekly Subcutaneous Doses With TransCon CNP in Children and Adolescents With Achondroplasia

Mirvetuximab Soravtansine (MIRV) With Carboplatin in Second-line Treatment of Folate Receptor Alpha (FRα) Expressing, Platinum-sensitive Epithelial Ovarian Cancer

Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI).

Study of Intratumoral (IT) Ulevostinag (MK-1454) in Combination With Intravenous (IV) Pembrolizumab (MK-3475) Compared to IV Pembrolizumab Alone as the First Line Treatment of Metastatic or Unresectable, Recurrent Head and Neck Squamous Cell Carcinoma (HNSCC) (MK-1454-002)

Randomized Salvage Radiation Therapy Plus Enzalutamide Post Prostatectomy

A Study of XMT-1660 in Participants With Solid Tumors

ZIP Study-OL Study of Safety, PK, Efficacy, PD, Immunogenicity of ATB200/AT2221 in Pediatrics Aged 0 to < 18 y.o. w/LOPD

A Study to Evaluate AZD2693 in Participants Who Are Carriers of the PNPLA3 148M Risk Allele With Non-cirrhotic Non-alcoholic Steatohepatitis With Fibrosis

Safety Study of Adenovirus Vector Engineered to Express hIL-12 in Combination With Activator Ligand to Treat Melanoma

A Study to Evaluate Efficacy and Safety of Intravenous Sabirnetug in Participants With Early Alzheimer's Disease (ALTITUDE-AD)

Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors

Ampligen in Chronic Fatigue Syndrome

Comparing Surgical and Endovascular Arteriovenous Fistula Creation

Pediatric Patients Aged 4 to 11 Years With APDS

A Study of Pembrolizumab (MK-3475) in Relapsed or Refractory Classical Hodgkin's Lymphoma (rrcHL) or Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL) (MK-3475-B68)

Stryker's Surgeon iD Mandible Reconstruction Plates: A Retrospective Post Market Follow Up